Peter Martin

机构：Cornell University, Weill Cornell Medicine · ORCID：0000-0001-7813-1551

发表论文 437 篇 · 总被引 12100 次 · h-index 51

代表论文

• Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium (2023 · Journal of Hematology & Oncology · 被引 14)
• Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐ GemOx : A Multicenter Cohort Study (2025 · American Journal of Hematology · 被引 12)
• A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities (2025 · Cell Reports Medicine · 被引 11)
• Multicenter Study of Mantle Cell Lymphoma Outcomes Following First-Line Bendamustine-Rituximab and Second-Line Bruton's Tyrosine Kinase Inhibitor Therapy (2023 · Blood · 被引 10)
• Defining optimal perioperative analgesia in patients undergoing laparotomy for advanced gynecologic malignancy: A randomized controlled trial (2024 · Gynecologic Oncology · 被引 9)
• Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma (2023 · Haematologica · 被引 9)